Eduardo Franco has served as an occasional paid consultant to pharmaceutical and biotechnology companies involved with HPV vaccines (GSK, Merck), HPV ... by the US FDA for commercial use in ...

The HPV vaccine, called Gardasil-9 — which has no live virus and is completely non-infectious — protects against the six types of HPV most likely to cause cancer, Eckert says. (These are strains 6, 11 ...

The HPV9 vaccine prevents high-risk HPV types that cause about 70 per cent of cervical cancers and 80 per cent of anal cancers. Publicly funded HPV immunization programs have been offered in ...

225,000-square-foot manufacturing plant that will produce bulk substance for Merck's Gardasil HPV vaccine. Merck has spent a total of more than $12 billion in expanding its U.S. manufacturing and ...

Shares in Moderna were ticking upwards today after Merck ... its COVID-19 vaccine, which is predicted to make around $21 billion in sales this year, but is its only commercial product and ...

“Merck & Co., Inc. (NYSE:MRK) was our second-largest detractor this quarter, declining -8.3%. MRK’s leading HPV vaccine, GARDASIL 9, faced challenges internationally due to inventory buildup ...

In this article, we are going to take a look at where Merck & Co Inc. (NYSE:MRK) stands against other undervalued S&P 500 stocks to buy now. Earlier on March 13, Michael Cuggino, President and ...

While it will have a big task taking on the established Prevnar franchise in the adult population, Merck has an opportunity to steal a march on Pfizer in the large paediatric pneumococcal vaccine ...

Gardasil vaccine protects against cancer-causing human papilloma virus or HPV infections. The pause announcement comes a month after Merck received approval in China for use of the vaccine in males.

In this article, we are going to take a look at where Merck & Co Inc. (NYSE:MRK) stands against other profitable value stocks to buy now. Matt Powers, Managing Partner at Powers Advisory Group ...